Difference between revisions of "Team:ASIJ Tokyo"
| Line 52: | Line 52: | ||
</div> | </div> | ||
<img src="https://static.igem.org/mediawiki/2018/e/ed/T--ASIJ_Tokyo--liverlogocut.png" id="liver"></img> | <img src="https://static.igem.org/mediawiki/2018/e/ed/T--ASIJ_Tokyo--liverlogocut.png" id="liver"></img> | ||
| − | + | <div id="subtitle"> | |
| − | + | <h1> Using Stem Cell and CRISPR Technology to Combat <br> Alpha-1 Antitrypsin Deficiency </h1> | |
| − | + | </div> | |
| − | + | </body> | |
</html> | </html> | ||
Revision as of 07:08, 31 August 2018
A1-AT
deLIVERy
